ScienceDex / Researcher record
Babu, Suma
- Massachusetts General Hospital (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Top 1% Funded
- Early Career
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2022 | $18,136,504 | 1 | #96 |
| 2023 | $21,339,216 | 2 | #73 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2022 · selected1 record
- FY20232 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2022 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Babu, Suma as a PI. Multi-PI records show the full award amount for context.
- 1UF1NS131791-01UF1Contact PIAn Expanded Access Protocol of Intravenous Trehalose Injection 90 mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis$18.1Maward amount
Award organization
Organizations that administered FY2022 awards listing Babu, Suma as a PI.
FY2022 award administered by Massachusetts General Hospital (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2022First NIH AwardMassachusetts General Hospital
- 2022$500K Cumulative Funding
- 2022$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022$5M Cumulative Funding
- 2022$10M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #96
- 2022Entered Top 25% NationallyRanked #96
- 2022Entered Top 10% NationallyRanked #96
- 2022Entered Top 5% NationallyRanked #96
- 2022Entered Top 1% NationallyRanked #96
- 2023$25M Cumulative Funding